INSULIN RESISTANCE AND METABOLIC SYNDROME: CURRENT CONCEPTS
Kalit so‘zlar:
Insulin resistance, metabolic syndrome, obesity, type 2 diabetes mellitus, cardiovascular diseaseAbstrak
Insulin resistance and metabolic syndrome are among the most significant metabolic disorders affecting global public health. These conditions are closely associated with obesity, type 2 diabetes mellitus, cardiovascular diseases, and various metabolic abnormalities. The present article examines contemporary concepts regarding the pathophysiological mechanisms, risk factors, diagnostic approaches, and treatment strategies related to insulin resistance and metabolic syndrome. Particular attention is given to the role of insulin resistance as a central factor in the development of metabolic syndrome and its complications. The article also discusses current preventive measures, including lifestyle modification and pharmacological interventions aimed at improving metabolic health and reducing cardiovascular risk. The findings highlight the importance of early diagnosis, comprehensive management, and evidence-based therapeutic approaches in preventing disease progression and improving long-term health outcomes
##plugins.themes.default.displayStats.downloads##
Havolalar
1. Fahed G., Aoun L., Bou Zerdan M., Allam S., Bouferraa Y. Metabolic syndrome: updates on pathophysiology and management // International Journal of Molecular Sciences. – 2022. – Vol. 23, № 2. – P. 786.
2. Abiri B., Vafa M. Obesity, diabetes mellitus, and metabolic syndrome // Clinical Nutrition Research. – 2022. – Vol. 11, № 4. – P. 331–339.
3. Petersen M.C., Shulman G.I. Mechanisms of insulin action and insulin resistance revisited // Physiological Reviews. – 2022. – Vol. 102, № 4. – P. 1741–1787.
4. Rochlani Y., Pothineni N.V.K., Mehta J.L. Metabolic syndrome: pathophysiology, management and future perspectives // Therapeutic Advances in Cardiovascular Disease. – 2022. – Vol. 16. – P. 1–15.
5. Peterseim C.M., Brown T.M., Johnson K.R. Metabolic syndrome: an updated review on diagnosis and treatment // Journal of the American Board of Family Medicine. – 2024. – Vol. 37, № 4. – P. 721–733.
6. Dhondge R.H., Patel S., Sharma A. A comprehensive review of metabolic syndrome and its role in cardiovascular disease and type 2 diabetes mellitus // Cureus. – 2024. – Vol. 16, № 8. – P. 1–12.
7. Lin Z., Zhang H., Wang X. Research advances in the therapy of metabolic syndrome // Frontiers in Pharmacology. – 2024. – Vol. 15. – P. 1–18.
8. Alawdi S.H., Al-Dholae M.A., Al-Shawky S.A. Metabolic syndrome and pharmacotherapy outcomes in patients with type 2 diabetes mellitus // Frontiers in Clinical Diabetes and Healthcare. – 2024. – Vol. 5. – P. 1–11
9. Liu J., Wang R., Tan S., Zhao X., Hou A. Association between insulin resistance, metabolic syndrome and its components: a systematic review and meta-analysis // Diabetology & Metabolic Syndrome. – 2024. – Vol. 16, № 1. – P. 1–15.
10. Hamooya B.M., Chanda D., Mweemba O. Metabolic syndrome: epidemiology, mechanisms and cardiovascular implications // Frontiers in Nutrition. – 2025. – Vol. 12. – P. 1–14.
11. Noubiap J.J., Bigna J.J., Nansseu J.R. Worldwide trends in metabolic syndrome from 2000 to 2023 // Nature Communications. – 2025. – Vol. 16, № 1. – P. 1–12.
12. Ballena-Caicedo J., Torres-Castro R., Diaz A. Global prevalence of insulin resistance in the adult population: a systematic review // BMC Endocrine Disorders. – 2025. – Vol. 25, № 1. – P. 1–13.
13. Yang B., Li X., Chen Y. Association of skipping breakfast with metabolic syndrome: a systematic review // Nutrients. – 2025. – Vol. 17, № 19. – P. 3155–3168.
14. Caretto A., Santarsiero A., Linsalata M. Targeting insulin resistance through nutrition // Nutrients. – 2026. – Vol. 18, № 7. – P. 1119–1134.
